Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments

The Movement Disorder Society (MDS) commissioned a revision of the UPDRS with the goals of improving instructions and definitions, more accurately evaluating milder features, and assessing patient‐reported outcomes and nonmotor features. To date, no study has evaluated longitudinal changes in components of the MDS‐UPDRS over time or correlated these with changes in other scales of various symptoms. We assessed Parts I and II of the MDS‐UPDRS (non‐Motor and Motor Experiences of Daily Living [nM‐EDL, M‐EDL]) as well as a number of other scales of motor, cognitive and behavioral function in a large population of patients (n = 383) with early‐ to mid‐stage Parkinson's disease (PD) who had previously participated in a trial of a putative disease‐modifying agent. Both parts of a MDS‐UPDRS showed significant change over the 3‐year follow‐up period, with M‐EDL scores declining to a greater extent than nM‐EDL. Both the scores and their changes over time correlated relatively well with other rating scales of similar disease aspects. Modest correlations with the original version of the UPDRS supported the increased attention to nonmotor symptoms as well as milder levels of severity in the MDS‐UPDRS. The M‐EDL was much more sensitive to change over time in these early‐ to mid‐stage patients than the original UPDRS Activities of Daily Living (ADL) scale. Finally, we showed no change over time in a small group of individuals with dopamine transporter single‐photon emission computed tomography scans without evidence for dopamine deficiency. The nM‐EDL and M‐EDL components of the MDS‐UPDRS provide an effective, relevant measure of change in the broad spectrum of symptoms of PD over the first decade of the disease. © 2013 International Parkinson and Movement Disorder Society

[1]  C. Tanner,et al.  A longitudinal program for biomarker development in Parkinson's disease: A feasibility study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[2]  P. Rabins,et al.  A comparison of nine scales to detect depression in Parkinson disease , 2012, Neurology.

[3]  Daniel Weintraub,et al.  Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[5]  David Oakes,et al.  (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. , 2004, Archives of neurology.

[6]  P. Lapuerta,et al.  The Hopkins Verbal Learning Test and Screening for Dementia , 2001, Dementia and Geriatric Cognitive Disorders.

[7]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[8]  Andrew J Lees,et al.  Validation of the MDS‐UPDRS Part I for nonmotor symptoms in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[9]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[10]  A. Larner,et al.  Addenbrooke's Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia , 2007, Clinical Neurology and Neurosurgery.

[11]  A M Stiggelbout,et al.  Assessment of cognition in Parkinson’s disease , 2003, Neurology.

[12]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[13]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[14]  L. Seeberger,et al.  Schwab & England: Standardization of administration , 2000, Movement disorders : official journal of the Movement Disorder Society.

[15]  C. Tanner,et al.  Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.

[16]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[17]  Eugene M. Johnson,et al.  MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE , 2008, Neurology.

[18]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[19]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[20]  A. Lang,et al.  Overview of the extranigral aspects of Parkinson disease. , 2009, Archives of neurology.

[21]  R. Fitzpatrick,et al.  Health‐related quality of life in parkinson's disease: A study of outpatient clinic attenders , 1997, Movement disorders : official journal of the Movement Disorder Society.